Why does enteric coating prevent stomach irritation with aspirin?

Why does enteric coating protect the stomach from aspirin irritation?

Enteric coatings are polymer barriers applied to tablets. They stay intact in the acidic environment of the stomach and dissolve only in the neutral pH of the small intestine. This keeps aspirin particles from contacting gastric mucosa directly.

Why are companies still developing new enteric coatings for aspirin?

Pharmaceutical firms continue to refine polymers such as methacrylic acid copolymers and cellulose acetate phthalate to improve dissolution consistency, reduce dose dumping, and handle variable gastric pH in older patients or those who take proton-pump inhibitors.

How does enteric-coated aspirin compare with plain aspirin in clinical outcomes?

Head-to-head studies show enteric-coated tablets reduce acute gastric mucosal injury and microbleeding compared with uncoated aspirin, but long-term cardiovascular protection appears equivalent once the drug is absorbed. Some patients still report upper gastrointestinal symptoms even with coated versions.

Can enteric-coated aspirin cause irritation despite the coating?

Yes. The coating can fail if tablets are crushed or chewed, or if gastric emptying is delayed. Patients taking concurrent nonsteroidal anti-inflammatory drugs or corticosteroids still carry a higher risk of ulcers and bleeding.

What happens if the coating does not dissolve properly?

Incomplete dissolution may lower bioavailability. Some formulations show delayed absorption, especially after meals, which can affect the quick antiplatelet effect needed in acute coronary settings.

When does aspirin patent protection end for enteric-coated versions?

Most basic aspirin patents expired decades ago. Current protection, if any, covers specific coating compositions or manufacturing processes rather than the drug itself. DrugPatentWatch.com tracks these secondary patents and their expiration dates.